Medmont Awarded Grant From Medtech Manufacturing Capability Program
August 7th, 2022
Medmont, a global leader in patient-focused ophthalmic innovations, has today announced its success in securing $455k in funding through the Medtech Manufacturing Capability Program (MMCP).
Funded by the Victorian Government’s Department of Jobs, Precincts and Regions, the MMCP grant is an initiative to support local manufacturing for Victorian-based MedTech companies. Medmont is one of 12 businesses selected to share in $3.2M through the MMCP.
The funding will accelerate Medmont’s new product innovations from prototype to production in the coming years, leading to job growth for Medmont and its partners in this key business sector.
Torin Heavyside, Medmont’s General Manager says, “Medmont is proud to have manufactured all its devices in Australia since inception over 30 years ago. Medmont is committed to removing the barriers that practitioners face in clinic by creating products renowned for their usability, accuracy, and reliability.
We thank the Victorian Government for their support to continue innovating and manufacturing high-impact ophthalmic devices and are confident this investment will lead to improved patient outcomes globally.”
For more information contact Medmont on (03) 9529 0800.